Centre médical Sheba
| Israël | Turquie | Espagne | |
| Chirurgie des tumeurs hypophysaires | de $28,000 | de $13,500 | de $25,000 |
Bookimed ne facture pas de frais supplémentaires pour les prix des Chirurgie des tumeurs hypophysaires. Les tarifs sont issus des listes de prix officielles des cliniques. Vous payez directement à la clinique lors de votre arrivée pour votre Chirurgie des tumeurs hypophysaires.
Bookimed s'engage pour votre sécurité. Nous ne travaillons qu'avec des établissements médicaux qui respectent des normes internationales élevées dans Chirurgie des tumeurs hypophysaires et qui possèdent les licences nécessaires pour accueillir des patients internationaux dans le monde entier.
Bookimed offre une assistance experte gratuite. Un coordinateur médical personnel vous accompagne avant, pendant et après votre traitement, en résolvant tous les problèmes. Vous n'êtes jamais seul dans votre parcours de Chirurgie des tumeurs hypophysaires.
Jour 1
Jour 2
Jour 3
Jour 4
Jour 5-7
Semaine 2
Semaine 3-6
Semaine 7
Veuillez noter que le délai de récupération de chaque patient peut varier en fonction de l'état de santé individuel et de la complexité de l'intervention chirurgicale.
Prof. Zvi Cohen is Director of the Neurosurgery Department and the Neuro-Oncology Unit at Sheba Medical Center. He is a neurosurgeon and neuro-oncology expert. He was included in Forbes Israel’s Best Doctors 2025. He leads clinical research on drug therapies for malignant brain tumors. He also founded Sheba’s brain tumor tissue bank.
He is board-certified in neurosurgery. He trained at Tel Aviv University. He completed fellowships in neuroradiology at Beth Israel and in neurosurgical oncology at MD Anderson. His practice covers complex brain, pituitary, spine, and spinal cord tumors. He has expertise in stereotactic biopsies, image-guided resections, intraoperative MRI, navigation systems, and radiosurgery. He is a member of the Society for Neuro-Oncology and the Israeli Association of Neurological Surgeons.
Professor Jair Bar, MD, PhD, is a thoracic oncologist and Deputy Director of the Cancer Center at Sheba Medical Center. He leads the Thoracic Oncology Unit. He treats lung cancer, including advanced non-small cell cases. His care includes medical oncology, radiotherapy, immunotherapy, and targeted therapy.
He runs a translational research lab focused on resistance to immunotherapy. He has published on exhaled-breath cancer metabolism and on angiogenesis inhibition in lung cancer.
He has chaired the Israel Lung Cancer Group since 2003. He is a member of the Israel Society of Clinical Oncology and Radiotherapy, the American Society of Clinical Oncology, and the American Association for Cancer Research. He is board-certified in Medical Oncology and Radiotherapy Oncology. He is a Senior Lecturer at Tel Aviv University.
Dr. Anton Wohl leads the Brain Tumors Unit at Sheba Medical Center (since 2026). He is a neurosurgeon specializing in neuro-oncology, brain tumor surgery, and stereotactic radiosurgery.
He performs complex tumor operations with intraoperative MRI and functional mapping. He also uses fluorescence guidance, neuronavigation, and awake craniotomy to help remove tumors safely and preserve function.
Accreditations: Israeli Board Certification in Neurosurgery; Israeli medical license; advanced international fellowships and training, including the Mayo Clinic (USA).
Research: author and co-author of peer-reviewed publications on glioblastoma, malignant brain tumors, radiosurgery, and experimental therapies.
Dr. Yaacov Lawrence, MA, MBBS, MRCP, is Chair of Radiation Oncology at Sheba Medical Center. He has nearly 30 years of experience in precision radiation oncology and neuro-oncology.
He is an expert in advanced radiation therapy and radiosurgery. He performs stereotactic radiosurgery for brain tumors. He leads Sheba’s GI Cancer Program in gastrointestinal oncology. He also provides precision care for lung and prostate cancers. He pioneered celiac plexus radiosurgery for severe pain from pancreatic cancer.
Training and credentials: MA and MBBS (Cambridge and UCLH); MRCP (RCP); Radiation Oncology fellowship (Thomas Jefferson University). Honors include the ASCO Young Investigator Award and Fellow of ASTRO (FASTRO). He has authored over 280 publications. He is Director of the Center for Translational Radiation Oncology and an Associate Professor at Tel Aviv University.